Literature DB >> 913924

Does glucagon play a role in the insulin resistance of patients with adult non-ketotic diabetes?

J M Olefsky, M A Sperling, G M Reaven.   

Abstract

Using a constant intravenous infusion technique we have measured in vivo insulin resistance in 17 normal subjects, five patients with chemical diabetes, and 13 non-ketotic diabetic patients with fasting hyperglycaemia (FBS greater than 120 mg/100 ml). All of the diabetic patients were non-obese. The results demonstrated that the diabetic patients were insulin resistant compared to normals and that the degree of insulin resistance was greater the more severe the diabetes. No differences in plasma glucagon levels were found among the different groups during the infusion studies. These results demonstrate that non-obese, non-ketotic diabetic patients are insulin resistant and that abnormalities in plasma glucagon concentrations do not account for this insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 913924     DOI: 10.1007/bf01223274

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  Metabolism of forearm tissues in man. Studies with glucagon.

Authors:  T Pozefsky; R G Tancredi; R T Moxley; J Dupre; J D Tobin
Journal:  Diabetes       Date:  1976-02       Impact factor: 9.461

Review 2.  The role of insulin resistance in the pathogenesis of diabetes mellitus.

Authors:  G M Reaven; J M Olefsky
Journal:  Adv Metab Disord       Date:  1978

3.  Development and application of a radioimmunoassay for plasma glucagon.

Authors:  M A Sperling; P V DeLamater; M Kazenelson; R H Fiser; D A Fisher
Journal:  Clin Chem       Date:  1974-05       Impact factor: 8.327

4.  Further evidence that insulin resistance exists in patients with chemical diabetes.

Authors:  H Ginsberg; J M Olefsky; G M Reaven
Journal:  Diabetes       Date:  1974-08       Impact factor: 9.461

5.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.

Authors:  B Desbuquois; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

Review 6.  Glucagon physiology and pathophysiology.

Authors:  R H Unger
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

7.  Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.

Authors:  R S Sherwin; M Fisher; R Hendler; P Felig
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

8.  Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.

Authors:  P Raskin; Y Fujita; R H Unger
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

9.  The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

10.  Decreased insulin binding to lymphocytes from diabetic subjects.

Authors:  J M Olefsky; G M Reaven
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  2 in total

Review 1.  Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status.

Authors:  M B Davidson
Journal:  West J Med       Date:  1985-02

2.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

Authors:  O G Kolterman; R S Gray; J Griffin; P Burstein; J Insel; J A Scarlett; J M Olefsky
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.